Ann: Noxopharm to Prioritise Cutting-Edge Chroma & Sofra Programs, page-61

RBx, I was starting to get concerned about you going missing in action.

You don't need to convince me that Noxopharm should be a strong Buy, But i do want to thank Mr market for the opportunity to top up on the cheap again, looks like i am not the only one.

Two pivots this in the SP this week lower selling volumes and people buying in large quantities at a time.

I feel that we may not need to wait for too long to cash in, I am not going to go in with my assessment but my 40 years of experience speaks to me, i could be wrong do your own research and invest carefully.